About 8 to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems. Although many who have this condition — called monoclonal B-cell lymphocytosis (MBL) — do not experience any symptoms, a new study shows they may have an elevated risk for several health complications, including melanoma, a form of skin cancer. The findings, by Mayo Clinic researchers, are published in a new paper in the Journal of Clinical Oncology.
Melanoma News
VMT01 Earns FDA Fast Track Designation in MC1R-Positive Melanoma
The novel agent VMT01 is designed to target and deliver 212Pb to MC1R-expressing tumors like metastatic melanoma.
Breaking the trend: Sweden sees skin cancer decline in under-50s for first time
The risk of skin cancer, malignant melanoma, now appears to be decreasing in Sweden—at least in those under 50, according to a new study.
Experts Report Moderate Patient Adherence to Melanoma Screening and Surveillance Program
Researchers tailored screening and surveillance schedules to individual risk of patients.